Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

Clinical trial NCT01852708 · COMPLETED

Trial details

NCT number: NCT01852708
Sponsor: Natera, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Trisomy 21 Trisomy 18 Trisomy 13 Sex Chromosome Abnormalities Microdeletion Syndromes

Start date: 2012-11-01
Primary completion: 2020-10-01
Enrollment: 1059

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.